Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ArcelorMittal (ADR) (MT), Nucor Corporation (NUE): The US Steel Industry Is Concerned

Page 1 of 2

The US steel market is facing headwinds due to low metal prices. There are many factors that could be causing this issue such as the declining prices of raw materials, all of which impact steel production. On the other hand, increased imports of Chinese steel into US is another reason of concern for these companies.

Despite these issues, investors can still find good opportunities and enter this market. The construction sector has been recovering and this could be advantageous for the steel industry.  Let’s take a look at the very competitive steel business.

The global steel king

ArcelorMittal (ADR) (NYSE:MT)

ArcelorMittal (ADR) (NYSE:MT), with its vertical integration and high degree of operating leverage, is well-positioned relative to other steelmakers. The main concern about the company is that most of its production is destined to the sluggish European market. That said, ArcelorMittal has arguments to show a little recovery.

The company has already beaten its guidance and has reaffirmed its expectations to beat its net debt guidance too. Consequently, covenant breaches have disappeared and have lowered the risk premium related to the stock.

ArcelorMittal (ADR) (NYSE:MT) is currently trading at 6.4 times the ratio of its enterprise value to its earnings before interest, taxes, depreciation and amortization (EV/EBITDA) for 2013 and 4.2 times its EV/EBITDA for 2014. Even if only a small share of the company’s EBITDA (around 7%) comes from the US, I think that ArcelorMittal (ADR) (NYSE:MT) (which trades at 33% of its book value) represents a long-term opportunity for those looking for exposure to the global steel market.

A leveraged US steel bet

United States Steel Corporation (NYSE:X) has proven to be one of the leading pack. In the US, the company has achieved an 80% self-sufficiency in coke and almost completely in iron ore. This vertical integration gives the company a cost advantage over its competitors as it sources the majority of its raw materials at cost and mitigates cost volatility, a winning card these days.

The company, with a net debt to EBITDA ratio of 4.6 times, is a leveraged play within the US steel industry.  The company’s fundamentals are ameliorating fast and there are positive points that should be highlighted.

The key aspect for this company is its European profitability, which has showed significant improvement (reaching its highest level since 2010.) United States Steel Corporation (NYSE:X) also paid the majority of its convertible notes due in 2014 and increased its liquidity to $2.5 billion. The company is currently trading at 8 times EV/EBITDA for 2013, but analysts expect the company to increase its earnings for 2014. This stock is the right bet for those who are looking for a risky US stock.

Nucor: The safest company

Nucor Corporation (NYSE:NUE) is the largest US steel manufacturer by production, and its mills are among the most modern and efficient in the world. Being the profitability champion within the steel sector, Nucor is investing for future growth. The company has invested $800 million of its 2013 capital expenditure target without incurring in the dangerous leverage that characterizes the steel industry. With a net debt to EBITDA ratio of 1.75 times, the company has a very strong balance sheet.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!